Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its
presentation at the BMO Capital Markets 2008 Focus on Healthcare
Conference on Wednesday, August 6, 2008. The presentation will provide
an overview of the Company and its clinical programs and is scheduled to
be broadcast live on Wednesday, August 6 at 11:45 a.m. Eastern Time. The
session may be accessed through the Company’s
web site (www.regeneron.com on
the Investor Relations page, under the Presentations heading) at the
time of the presentation. An archived version of the presentation will
be available after the live webcast through September 5, 2008.
Additional information about Regeneron and recent news releases are
available on the Regeneron worldwide web site at www.regeneron.com.
Regeneron is a fully integrated biopharmaceutical company that
discovers, develops, and commercializes medicines for the treatment of
serious medical conditions. In addition to ARCALYST®
(rilonacept) Injection for Subcutaneous Use, its first commercialized
product, Regeneron has therapeutic candidates in clinical trials for the
potential treatment of cancer, eye diseases, and inflammatory diseases
and has preclinical programs in other diseases and disorders.
Regeneron Pharmaceuticals, Inc.
Investor Relations, 914-345-7640
invest@regeneron.com
or
Laura
Lindsay, 914-345-7800
laura.lindsay@regeneron.com
or
Lauren
Tortorete, 212-845-5609
ltortorete@biosector2.com
